Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis
BACKGROUND:General anesthesia (GA) is often selected for cesarean deliveries (CD) with placenta previa and suspected morbidly adherent placenta (MAP) due to increased risk of hemorrhage and hysterectomy. We reviewed maternal outcomes and risk factors for conversion to GA in a cohort of patients unde...
Gespeichert in:
Veröffentlicht in: | Anesthesia and analgesia 2018-10, Vol.127 (4), p.930-938 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 938 |
---|---|
container_issue | 4 |
container_start_page | 930 |
container_title | Anesthesia and analgesia |
container_volume | 127 |
creator | Markley, John C. Farber, Michaela K. Perlman, Nicola C. Carusi, Daniela A. |
description | BACKGROUND:General anesthesia (GA) is often selected for cesarean deliveries (CD) with placenta previa and suspected morbidly adherent placenta (MAP) due to increased risk of hemorrhage and hysterectomy. We reviewed maternal outcomes and risk factors for conversion to GA in a cohort of patients undergoing CD and hysterectomy under neuraxial anesthesia (NA).
METHODS:We performed a single-center, retrospective cohort study of parturients undergoing nonemergent CD for placenta previa with suspected MAP from 1997 to 2015. Patients were classified according to whether they received GA, NA, or intraoperative conversion from NA to GA. The primary outcome measure was postoperative acuity, defined as the need for intensive care unit admission, arterial embolization, reoperation, or ongoing transfusion with ≥3 units packed red blood cells. We additionally identified variables positively associated with intraoperative conversion from NA to GA during hysterectomy. Confounding was controlled with logistic regression models.
RESULTS:Of 129 patients undergoing nonemergent CD for placenta previa with suspected MAP, 122 (95%) received NA as the primary anesthetic. NA was selected in the majority of patients with a body mass index ≥40 kg/m (9 of 10, 90%), a history of ≥3 prior CDs (18 of 20, 90%), suspected placenta increta or percreta (29 of 35, 83%), and Mallampati classification ≥3 (19 of 21, 90%). Of 72 patients with NA at the time of delivery who required hysterectomy, 15 (21%) required conversion to GA intraoperatively. Converted patients had a higher rate of major packed red blood cell transfusion (60% vs 25%; P = .01), with similar rates of massive transfusion (9% vs 7%; P = 1.0). Converted patients also had a higher incidence of postoperative acuity (47% vs 4%; P < .0001), including 5 intensive care unit admissions for airway management after large-volume resuscitation. After adjusting for multiple confounders, the only independent predictors of conversion among hysterectomy patients were longer surgical duration (adjusted odds ratio 1.54, 95% CI, 1.01.2.42) and a history of ≥3 prior CDs (adjusted odds ratio, 6.45; 95% CI, 1.12.45.03).
CONCLUSIONS:NA was applied to and successfully used in the majority of patients with suspected MAP. Our findings support selective conversion to GA during hysterectomy in these patients, focusing on those with the highest levels of surgical complexity. |
doi_str_mv | 10.1213/ANE.0000000000003314 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2008887365</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2008887365</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3774-1e5bc05b7c477288cd887e2c51c4c364c126e0fa413094ce395d6c6ffcd02c493</originalsourceid><addsrcrecordid>eNqFkctO5DAQRS3ECHqAP0DISzYBv5LY7KLmKfESM6NZRm6nQgzupLETmP4A_hs3zSDEAixZVlnn3ir7IrRNyR5llO8Xl0d75MPinIoVNKIpy5I8VXIVjRa3CVNKraOfIdzFkhKZraF1poSkguUj9HwJg9f_rHa4aCH0DQSr8eHgbXuLxxC0B93iQ3D2Efwc153H104baHuNrz08Rviv7Rv8awgzMD1U-KLzE1u5OS6qBnwE3wUHuMA30PvuFY2GsaV282DDJvpRaxdg6-3cQH-Oj36PT5Pzq5OzcXGeGJ7nIqGQTgxJJ7kRec6kNJWUOTCTUiMMz4ShLANSa0E5UcIAV2mVmayuTUWYEYpvoN2l78x3D0N8bjm1wYBzuoVuCCUjREZLnqURFUvUxHmDh7qceTvVfl5SUi4CKGMA5ecAomznrcMwmUL1Lvr_4xGQS-Cpcz34cO-GJ_BlA9r1zXfe4gvpK5dylTBCJV0USdyM8xe3paKp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2008887365</pqid></control><display><type>article</type><title>Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Markley, John C. ; Farber, Michaela K. ; Perlman, Nicola C. ; Carusi, Daniela A.</creator><creatorcontrib>Markley, John C. ; Farber, Michaela K. ; Perlman, Nicola C. ; Carusi, Daniela A.</creatorcontrib><description>BACKGROUND:General anesthesia (GA) is often selected for cesarean deliveries (CD) with placenta previa and suspected morbidly adherent placenta (MAP) due to increased risk of hemorrhage and hysterectomy. We reviewed maternal outcomes and risk factors for conversion to GA in a cohort of patients undergoing CD and hysterectomy under neuraxial anesthesia (NA).
METHODS:We performed a single-center, retrospective cohort study of parturients undergoing nonemergent CD for placenta previa with suspected MAP from 1997 to 2015. Patients were classified according to whether they received GA, NA, or intraoperative conversion from NA to GA. The primary outcome measure was postoperative acuity, defined as the need for intensive care unit admission, arterial embolization, reoperation, or ongoing transfusion with ≥3 units packed red blood cells. We additionally identified variables positively associated with intraoperative conversion from NA to GA during hysterectomy. Confounding was controlled with logistic regression models.
RESULTS:Of 129 patients undergoing nonemergent CD for placenta previa with suspected MAP, 122 (95%) received NA as the primary anesthetic. NA was selected in the majority of patients with a body mass index ≥40 kg/m (9 of 10, 90%), a history of ≥3 prior CDs (18 of 20, 90%), suspected placenta increta or percreta (29 of 35, 83%), and Mallampati classification ≥3 (19 of 21, 90%). Of 72 patients with NA at the time of delivery who required hysterectomy, 15 (21%) required conversion to GA intraoperatively. Converted patients had a higher rate of major packed red blood cell transfusion (60% vs 25%; P = .01), with similar rates of massive transfusion (9% vs 7%; P = 1.0). Converted patients also had a higher incidence of postoperative acuity (47% vs 4%; P < .0001), including 5 intensive care unit admissions for airway management after large-volume resuscitation. After adjusting for multiple confounders, the only independent predictors of conversion among hysterectomy patients were longer surgical duration (adjusted odds ratio 1.54, 95% CI, 1.01.2.42) and a history of ≥3 prior CDs (adjusted odds ratio, 6.45; 95% CI, 1.12.45.03).
CONCLUSIONS:NA was applied to and successfully used in the majority of patients with suspected MAP. Our findings support selective conversion to GA during hysterectomy in these patients, focusing on those with the highest levels of surgical complexity.</description><identifier>ISSN: 0003-2999</identifier><identifier>EISSN: 1526-7598</identifier><identifier>DOI: 10.1213/ANE.0000000000003314</identifier><identifier>PMID: 29481427</identifier><language>eng</language><publisher>United States: International Anesthesia Research Society</publisher><subject>Adult ; Anesthesia, Conduction - adverse effects ; Anesthesia, Conduction - methods ; Anesthesia, General ; Anesthesia, Obstetrical - adverse effects ; Anesthesia, Obstetrical - methods ; Boston ; Cesarean Section - adverse effects ; Female ; Humans ; Hysterectomy - adverse effects ; Middle Aged ; Placenta Accreta - diagnosis ; Placenta Accreta - physiopathology ; Placenta Accreta - surgery ; Placenta Previa - diagnosis ; Placenta Previa - physiopathology ; Placenta Previa - surgery ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; Pregnancy ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome ; Young Adult</subject><ispartof>Anesthesia and analgesia, 2018-10, Vol.127 (4), p.930-938</ispartof><rights>International Anesthesia Research Society</rights><rights>2018 International Anesthesia Research Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3774-1e5bc05b7c477288cd887e2c51c4c364c126e0fa413094ce395d6c6ffcd02c493</citedby><cites>FETCH-LOGICAL-c3774-1e5bc05b7c477288cd887e2c51c4c364c126e0fa413094ce395d6c6ffcd02c493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00000539-201810000-00023$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4594,27903,27904,65210</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29481427$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Markley, John C.</creatorcontrib><creatorcontrib>Farber, Michaela K.</creatorcontrib><creatorcontrib>Perlman, Nicola C.</creatorcontrib><creatorcontrib>Carusi, Daniela A.</creatorcontrib><title>Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis</title><title>Anesthesia and analgesia</title><addtitle>Anesth Analg</addtitle><description>BACKGROUND:General anesthesia (GA) is often selected for cesarean deliveries (CD) with placenta previa and suspected morbidly adherent placenta (MAP) due to increased risk of hemorrhage and hysterectomy. We reviewed maternal outcomes and risk factors for conversion to GA in a cohort of patients undergoing CD and hysterectomy under neuraxial anesthesia (NA).
METHODS:We performed a single-center, retrospective cohort study of parturients undergoing nonemergent CD for placenta previa with suspected MAP from 1997 to 2015. Patients were classified according to whether they received GA, NA, or intraoperative conversion from NA to GA. The primary outcome measure was postoperative acuity, defined as the need for intensive care unit admission, arterial embolization, reoperation, or ongoing transfusion with ≥3 units packed red blood cells. We additionally identified variables positively associated with intraoperative conversion from NA to GA during hysterectomy. Confounding was controlled with logistic regression models.
RESULTS:Of 129 patients undergoing nonemergent CD for placenta previa with suspected MAP, 122 (95%) received NA as the primary anesthetic. NA was selected in the majority of patients with a body mass index ≥40 kg/m (9 of 10, 90%), a history of ≥3 prior CDs (18 of 20, 90%), suspected placenta increta or percreta (29 of 35, 83%), and Mallampati classification ≥3 (19 of 21, 90%). Of 72 patients with NA at the time of delivery who required hysterectomy, 15 (21%) required conversion to GA intraoperatively. Converted patients had a higher rate of major packed red blood cell transfusion (60% vs 25%; P = .01), with similar rates of massive transfusion (9% vs 7%; P = 1.0). Converted patients also had a higher incidence of postoperative acuity (47% vs 4%; P < .0001), including 5 intensive care unit admissions for airway management after large-volume resuscitation. After adjusting for multiple confounders, the only independent predictors of conversion among hysterectomy patients were longer surgical duration (adjusted odds ratio 1.54, 95% CI, 1.01.2.42) and a history of ≥3 prior CDs (adjusted odds ratio, 6.45; 95% CI, 1.12.45.03).
CONCLUSIONS:NA was applied to and successfully used in the majority of patients with suspected MAP. Our findings support selective conversion to GA during hysterectomy in these patients, focusing on those with the highest levels of surgical complexity.</description><subject>Adult</subject><subject>Anesthesia, Conduction - adverse effects</subject><subject>Anesthesia, Conduction - methods</subject><subject>Anesthesia, General</subject><subject>Anesthesia, Obstetrical - adverse effects</subject><subject>Anesthesia, Obstetrical - methods</subject><subject>Boston</subject><subject>Cesarean Section - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Hysterectomy - adverse effects</subject><subject>Middle Aged</subject><subject>Placenta Accreta - diagnosis</subject><subject>Placenta Accreta - physiopathology</subject><subject>Placenta Accreta - surgery</subject><subject>Placenta Previa - diagnosis</subject><subject>Placenta Previa - physiopathology</subject><subject>Placenta Previa - surgery</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>Pregnancy</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0003-2999</issn><issn>1526-7598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctO5DAQRS3ECHqAP0DISzYBv5LY7KLmKfESM6NZRm6nQgzupLETmP4A_hs3zSDEAixZVlnn3ir7IrRNyR5llO8Xl0d75MPinIoVNKIpy5I8VXIVjRa3CVNKraOfIdzFkhKZraF1poSkguUj9HwJg9f_rHa4aCH0DQSr8eHgbXuLxxC0B93iQ3D2Efwc153H104baHuNrz08Rviv7Rv8awgzMD1U-KLzE1u5OS6qBnwE3wUHuMA30PvuFY2GsaV282DDJvpRaxdg6-3cQH-Oj36PT5Pzq5OzcXGeGJ7nIqGQTgxJJ7kRec6kNJWUOTCTUiMMz4ShLANSa0E5UcIAV2mVmayuTUWYEYpvoN2l78x3D0N8bjm1wYBzuoVuCCUjREZLnqURFUvUxHmDh7qceTvVfl5SUi4CKGMA5ecAomznrcMwmUL1Lvr_4xGQS-Cpcz34cO-GJ_BlA9r1zXfe4gvpK5dylTBCJV0USdyM8xe3paKp</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Markley, John C.</creator><creator>Farber, Michaela K.</creator><creator>Perlman, Nicola C.</creator><creator>Carusi, Daniela A.</creator><general>International Anesthesia Research Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20181001</creationdate><title>Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis</title><author>Markley, John C. ; Farber, Michaela K. ; Perlman, Nicola C. ; Carusi, Daniela A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3774-1e5bc05b7c477288cd887e2c51c4c364c126e0fa413094ce395d6c6ffcd02c493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Anesthesia, Conduction - adverse effects</topic><topic>Anesthesia, Conduction - methods</topic><topic>Anesthesia, General</topic><topic>Anesthesia, Obstetrical - adverse effects</topic><topic>Anesthesia, Obstetrical - methods</topic><topic>Boston</topic><topic>Cesarean Section - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Hysterectomy - adverse effects</topic><topic>Middle Aged</topic><topic>Placenta Accreta - diagnosis</topic><topic>Placenta Accreta - physiopathology</topic><topic>Placenta Accreta - surgery</topic><topic>Placenta Previa - diagnosis</topic><topic>Placenta Previa - physiopathology</topic><topic>Placenta Previa - surgery</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>Pregnancy</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Markley, John C.</creatorcontrib><creatorcontrib>Farber, Michaela K.</creatorcontrib><creatorcontrib>Perlman, Nicola C.</creatorcontrib><creatorcontrib>Carusi, Daniela A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Markley, John C.</au><au>Farber, Michaela K.</au><au>Perlman, Nicola C.</au><au>Carusi, Daniela A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis</atitle><jtitle>Anesthesia and analgesia</jtitle><addtitle>Anesth Analg</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>127</volume><issue>4</issue><spage>930</spage><epage>938</epage><pages>930-938</pages><issn>0003-2999</issn><eissn>1526-7598</eissn><abstract>BACKGROUND:General anesthesia (GA) is often selected for cesarean deliveries (CD) with placenta previa and suspected morbidly adherent placenta (MAP) due to increased risk of hemorrhage and hysterectomy. We reviewed maternal outcomes and risk factors for conversion to GA in a cohort of patients undergoing CD and hysterectomy under neuraxial anesthesia (NA).
METHODS:We performed a single-center, retrospective cohort study of parturients undergoing nonemergent CD for placenta previa with suspected MAP from 1997 to 2015. Patients were classified according to whether they received GA, NA, or intraoperative conversion from NA to GA. The primary outcome measure was postoperative acuity, defined as the need for intensive care unit admission, arterial embolization, reoperation, or ongoing transfusion with ≥3 units packed red blood cells. We additionally identified variables positively associated with intraoperative conversion from NA to GA during hysterectomy. Confounding was controlled with logistic regression models.
RESULTS:Of 129 patients undergoing nonemergent CD for placenta previa with suspected MAP, 122 (95%) received NA as the primary anesthetic. NA was selected in the majority of patients with a body mass index ≥40 kg/m (9 of 10, 90%), a history of ≥3 prior CDs (18 of 20, 90%), suspected placenta increta or percreta (29 of 35, 83%), and Mallampati classification ≥3 (19 of 21, 90%). Of 72 patients with NA at the time of delivery who required hysterectomy, 15 (21%) required conversion to GA intraoperatively. Converted patients had a higher rate of major packed red blood cell transfusion (60% vs 25%; P = .01), with similar rates of massive transfusion (9% vs 7%; P = 1.0). Converted patients also had a higher incidence of postoperative acuity (47% vs 4%; P < .0001), including 5 intensive care unit admissions for airway management after large-volume resuscitation. After adjusting for multiple confounders, the only independent predictors of conversion among hysterectomy patients were longer surgical duration (adjusted odds ratio 1.54, 95% CI, 1.01.2.42) and a history of ≥3 prior CDs (adjusted odds ratio, 6.45; 95% CI, 1.12.45.03).
CONCLUSIONS:NA was applied to and successfully used in the majority of patients with suspected MAP. Our findings support selective conversion to GA during hysterectomy in these patients, focusing on those with the highest levels of surgical complexity.</abstract><cop>United States</cop><pub>International Anesthesia Research Society</pub><pmid>29481427</pmid><doi>10.1213/ANE.0000000000003314</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-2999 |
ispartof | Anesthesia and analgesia, 2018-10, Vol.127 (4), p.930-938 |
issn | 0003-2999 1526-7598 |
language | eng |
recordid | cdi_proquest_miscellaneous_2008887365 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adult Anesthesia, Conduction - adverse effects Anesthesia, Conduction - methods Anesthesia, General Anesthesia, Obstetrical - adverse effects Anesthesia, Obstetrical - methods Boston Cesarean Section - adverse effects Female Humans Hysterectomy - adverse effects Middle Aged Placenta Accreta - diagnosis Placenta Accreta - physiopathology Placenta Accreta - surgery Placenta Previa - diagnosis Placenta Previa - physiopathology Placenta Previa - surgery Postoperative Complications - etiology Postoperative Complications - therapy Pregnancy Retrospective Studies Risk Assessment Risk Factors Time Factors Treatment Outcome Young Adult |
title | Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A08%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuraxial%20Anesthesia%20During%20Cesarean%20Delivery%20for%20Placenta%20Previa%20With%20Suspected%20Morbidly%20Adherent%20Placenta:%20A%20Retrospective%20Analysis&rft.jtitle=Anesthesia%20and%20analgesia&rft.au=Markley,%20John%20C.&rft.date=2018-10-01&rft.volume=127&rft.issue=4&rft.spage=930&rft.epage=938&rft.pages=930-938&rft.issn=0003-2999&rft.eissn=1526-7598&rft_id=info:doi/10.1213/ANE.0000000000003314&rft_dat=%3Cproquest_cross%3E2008887365%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2008887365&rft_id=info:pmid/29481427&rfr_iscdi=true |